CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory to Sales
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Ani Pharmaceuticals Inc  (NASDAQ: ANIP)
Other Ticker:  
 
 

Ani Pharmaceuticals Inc Accounts Receivables Turnover Ratio from the first quarter 2025 to the first quarter 2024

Quarterly Results, Trends, Rankings, Statistics



 
Ani Pharmaceuticals Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2025 to a ratio of 3.35, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the first quarter 2025. Average receivable collection period, for the Ani Pharmaceuticals Inc in Mar 31 2025 quarter, has decreased to 109 days, compared to 112 days, in the Dec 31 2024 quarter.

If we take a look into Healthcare sector 253 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1837, from overall ranking in the forth quarter 2024 at 3046.

What is Receivable Turnover Ratio?
What is Ani Pharmaceuticals Inc Selling?


What is Receivable Turnover Ratio?




ANIP Receivables Turnover Ratio (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Receivable Change 27.79 % 36.8 % 9.8 % -3.95 % -1.31 %
Y / Y Revenue Change 43.43 % 44.75 % 12.52 % 18.44 % 28.7 %
Receivable Turnover Ratio (TTM) 3.35 3.25 3.19 3.17 3.02
ANIP's Total Ranking # 1837 # 3046 # 3076 # 1336 # 1021
Accounts Receivable average collection period days 109 112 114 115 121
Seq. Receivable Change -0.63 % 12.92 % 18.22 % -3.67 % 6.38 %
Seq. Revenue Change 3.44 % 28.48 % 7.46 % 0.44 % 4.39 %

New: More ANIP's historic Receivables Turnover Ratios >>

Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 85
Healthcare Sector # 254
Overall Market # 1837

Receivable Turnover Ratio Statistics
High Average Low
4.92 3.14 1.96
(Dec. 30, 2014)   (Jun 30 2022)





ANIP Company Profile • Back to ANIP Efficiency Comparisons • Compare ANIP Receivables Turnover Ratio to its Competitors

Financial Statements
Ani Pharmaceuticals Inc's Accounts Receivable $ 220 Millions Visit ANIP's Balance sheet
Ani Pharmaceuticals Inc's Sales TTM $ 674 Millions Visit ANIP's Income Statement
Sources of ANIP's Revenues Visit ANIP's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ANIP's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ANIP's Growth Rates ANIP's Roa ANIP's Inventory Turnover Ratio ANIP's Dividend Comparisons
ANIP's Profitability Ratios ANIP's Roi ANIP's Asset Turnover Ratio ANIP's Dividend Growth
ANIP's Valuation Ratios ANIP's Roe ANIP's Financial Strength Ratios ANIP's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2025 Receivable at quarter ending Mar 31 2025
Harmony Biosciences Holdings inc   8.41 $ 743.527  Millions$ 88.415  Millions
Insulet Corporation  8.41 $ 2,198.900  Millions$ 261.575  Millions
Editas Medicine Inc   8.36 $ 35.837  Millions$ 4.287  Millions
Zynex inc   8.34 $ 169.017  Millions$ 20.277  Millions
Madrigal Pharmaceuticals Inc   8.32 $ 317.383  Millions$ 38.153  Millions
Evolus Inc   8.32 $ 380.295  Millions$ 45.732  Millions
Acadia Healthcare Company Inc   8.22 $ 3,156.417  Millions$ 383.823  Millions
Clearpoint Neuro Inc   8.21 $ 32.236  Millions$ 3.929  Millions
Atricure Inc   8.18 $ 478.884  Millions$ 58.535  Millions
Radnet Inc   8.16 $ 1,869.356  Millions$ 229.124  Millions
Jaguar Health Inc   8.10 $ 11.552  Millions$ 1.427  Millions
Henry Schein Inc   8.07 $ 12,669.000  Millions$ 1,569.750  Millions
Elutia Inc   8.05 $ 23.321  Millions$ 2.896  Millions
Becton Dickinson And Company  8.03 $ 20,867.000  Millions$ 2,598.500  Millions
Sotera Health Company  7.91 $ 1,106.612  Millions$ 139.911  Millions
Arcturus Therapeutics Holdings Inc   7.89 $ 143.680  Millions$ 18.208  Millions
Ensign Group Inc  7.85 $ 4,423.354  Millions$ 563.789  Millions
Bioxcel Therapeutics Inc   7.83 $ 1.852  Millions$ 0.237  Millions
Adapthealth Corp   7.80 $ 3,246.360  Millions$ 416.192  Millions
Maxcyte inc   7.79 $ 37.675  Millions$ 4.837  Millions
Axogen inc   7.77 $ 194.520  Millions$ 25.045  Millions
Tenet Healthcare Corp  7.77 $ 20,520.000  Millions$ 2,642.500  Millions
10x Genomics Inc   7.76 $ 611.398  Millions$ 78.810  Millions
Alpha Teknova Inc   7.74 $ 37.029  Millions$ 4.783  Millions
Iridex Corp  7.74 $ 48.099  Millions$ 6.214  Millions
Idexx Laboratories Inc  7.69 $ 3,931.236  Millions$ 511.474  Millions
Alphatec Holdings Inc   7.67 $ 641.907  Millions$ 83.726  Millions
Irhythm Technologies Inc   7.64 $ 618.231  Millions$ 80.880  Millions
Aveanna Healthcare Holdings Inc   7.62 $ 2,093.077  Millions$ 274.610  Millions
Exelixis Inc   7.58 $ 2,298.922  Millions$ 303.341  Millions

Date modified: 2025-05-11T15:45:03+00:00



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright � 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com